The Australasian Journal of Dermatology This is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.

A photo-distributed rash and eczematous eruptions in two siblings-A diagnostic conundrum
Australas J Dermatol. 2024 Apr 22. doi: 10.1111/ajd.14295. Online ahead of print.NO ABSTRACTPMID:38646889 | DOI:10.1111/ajd.14295 (Source: The Australasian Journal of Dermatology)
Source: The Australasian Journal of Dermatology - April 22, 2024 Category: Dermatology Authors: Kittu Malhi Akash Mustari Sukhdeep Singh Anoop Kumar Pandiarajan Vignesh Dipankar De Sanjeev Handa Rahul Mahajan Source Type: research

Evaluating the role of bone scan in diagnosing calciphylaxis in practice-A retrospective case series of patients who were clinically managed for calciphylaxis despite resulting negative on initial biopsy
Australas J Dermatol. 2024 Apr 20. doi: 10.1111/ajd.14263. Online ahead of print.NO ABSTRACTPMID:38641920 | DOI:10.1111/ajd.14263 (Source: The Australasian Journal of Dermatology)
Source: The Australasian Journal of Dermatology - April 20, 2024 Category: Dermatology Authors: Emilee Herringshaw Maximilian Kinne Renee Joyce Fnu Nutan Source Type: research

Dupilumab for chronic actinic dermatitis: A case series and review of the literature
Australas J Dermatol. 2024 Apr 17. doi: 10.1111/ajd.14293. Online ahead of print.NO ABSTRACTPMID:38629787 | DOI:10.1111/ajd.14293 (Source: The Australasian Journal of Dermatology)
Source: The Australasian Journal of Dermatology - April 17, 2024 Category: Dermatology Authors: Zachary Holmes Peter Foley Chris Baker Benjamin S Daniel Source Type: research

Use of biologics for psoriasis in solid organ transplant recipients
We report a case from our institution of a 29-year-old man with a history of psoriasis, who underwent a kidney transplant and later developed erythroderma. He did not respond to traditional treatments and was successfully treated with adalimumab, leading to the discontinuation of MMF. We also reviewed literature in solid organ transplant patients with psoriasis. Our findings, based on 10 articles, indicate a cautious approach to using biologics in this group, with further research needed for efficacy and safety.PMID:38623950 | DOI:10.1111/ajd.14292 (Source: The Australasian Journal of Dermatology)
Source: The Australasian Journal of Dermatology - April 16, 2024 Category: Dermatology Authors: Marta Costa Blasco Claire Doyle Sophie Diong Siona Ni Raghallaigh Source Type: research

Successful treatment of dyshidrotic palmoplantar eczema with tralokinumab
Australas J Dermatol. 2024 Apr 14. doi: 10.1111/ajd.14268. Online ahead of print.ABSTRACTDyshidrotic palmoplantar eczema or pompholyx is considered to be a part of the spectrum of atopic dermatitis with a significant impact on the quality of life and limited treatment options. Tralokinumab is a new fully human monoclonal antibody which neutralizes interleukin 13, a chief cytokine in itch pathogenesis and skin barrier defects. Tralokinumab is FDA-approved for the treatment of atopic dermatitis in adults and EMA-approved for the treatment of atopic dermatitis in adults and adolescents. We, hereby, report a 40-year-old female...
Source: The Australasian Journal of Dermatology - April 15, 2024 Category: Dermatology Authors: Nisha V Parmar Anwar Al Hammadi Source Type: research

Dermatitis and prolonged dysesthesia from the poisonous wood nettle, Dendrocnide meyeniana (Urticaceae)
Australas J Dermatol. 2024 Apr 14. doi: 10.1111/ajd.14252. Online ahead of print.NO ABSTRACTPMID:38616498 | DOI:10.1111/ajd.14252 (Source: The Australasian Journal of Dermatology)
Source: The Australasian Journal of Dermatology - April 15, 2024 Category: Dermatology Authors: Johannes F Dayrit Bryan Edgar K Guevara Lunardi Bintanjoyo Scott A Norton Source Type: research

Successful use of adalimumab in treating granuloma faciale resistant to traditional therapies
Australas J Dermatol. 2024 Apr 14. doi: 10.1111/ajd.14260. Online ahead of print.NO ABSTRACTPMID:38616534 | DOI:10.1111/ajd.14260 (Source: The Australasian Journal of Dermatology)
Source: The Australasian Journal of Dermatology - April 15, 2024 Category: Dermatology Authors: Martina Mussi Corrado Zengarini Filippo Viviani Lidia Sacchelli Alessandro Pileri Federico Bardazzi Source Type: research

Brodalumab for moderate-severe hidradenitis suppurativa: An open-label multicentric cohort study in real clinical practice
CONCLUSIONS: Brodalumab seems to be effective and safe in patients with moderate to severe HS, even in those that did not respond to adalimumab, which, at the moment, is the only widely approved biologic for this indication. Thus, it stands as an interesting option for the treatment of HS.PMID:38597096 | DOI:10.1111/ajd.14267 (Source: The Australasian Journal of Dermatology)
Source: The Australasian Journal of Dermatology - April 10, 2024 Category: Dermatology Authors: Guiovana Fernanda Osorio-G ómez Juan Ortiz- Álvarez Delia Diaz-Ceca Cesar Guijarro-S ánchez Juli án Conejo-Mir Sánchez Pablo Fern ández Crehuet Source Type: research

Switch from adalimumab to brodalumab as a possible trigger factor for the onset of pyoderma gangrenosum
Australas J Dermatol. 2024 Apr 10. doi: 10.1111/ajd.14266. Online ahead of print.NO ABSTRACTPMID:38597123 | DOI:10.1111/ajd.14266 (Source: The Australasian Journal of Dermatology)
Source: The Australasian Journal of Dermatology - April 10, 2024 Category: Dermatology Authors: Giorgia Salvia Matteo Bevilacqua Flavia Manzo Margiotta Alessandra Michelucci Giammarco Granieri Cristian Fidanzi Valentina Dini Marco Romanelli Carlo Mazzatenta Source Type: research